Oncology PatientsNCT06954506
The Effect of Reiki on Hopelessness Level
A study testing Reiki Group in people with Oncology Patients, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
Trial summary
This quasi-experimental study aims to examine the effect of Reiki on the level of hopelessness in oncology patients. The study was conducted at İzmir Tepecik Training and Research Hospital with 32 patients in both experimental and control groups. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Oncology Patients
- What is being tested?
- Reiki Group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Apr 2023to 31 Mar 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
inclusion criteria: Receiving treatment at the Outpatient Chemotherapy Unit of İzmir Tepecik Training and Research Hospital University of Health Sciences, Diagnosed with cancer, Aged 18 and over, Willing to participate in the research
exclusion criteria: Not willing to participate in the research, Having communication problems
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effect of Reiki on Hopelessness Level in Oncology Patients Receiving Chemotherapy Treatment; Randomised Controlled Trial
This quasi-experimental study aims to examine the effect of Reiki on the level of hopelessness in oncology patients.
The study was conducted at İzmir Tepecik Training and Research Hospital with 32 patients in both experimental and control groups. Patients performed Reiki daily for a week following each chemotherapy session for 4 cycles. Data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews. Ethical approval was obtained, and data were analyzed using SPSS.
Read the detailed description
Reiki is considered a complementary and alternative therapy method that can be effective in coping with such emotional challenges and enhancing psychological well-being. It is thought that Reiki practices, by regulating the flow of energy and providing deep relaxation, can reduce individuals' levels of hopelessness and improve overall quality of life. This study will investigate the effect of Reiki practices on the levels of hopelessness in oncology patients.
- Conditions
- Oncology Patients
- Being tested
- Reiki Group
- Keywords
- Reiki; oncology; hopelessness
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Reiki GroupBehavioural
Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
| Study group | Role | What they receive |
|---|---|---|
| Reiki Group | Experimental | Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week. Receives: Behavioral: Reiki Group |
| control group | No intervention | Only data collection forms were filled in the control group. No intervention was made. |
What is being measured
The primary outcome is the main question the study is designed to answer.
The research data will be collected using the "Individual Information Form" and the "Beck Hopelessness Scale" prepared by the researchers in line with the literature.
Individual Information Form: The form prepared by the researchers consists of 14 questions.
Beck Hopelessness Scale: The Beck Hopelessness Scale was developed by Beck and colleagues in 1974 to determine the degree of pessimism an individual has about the future. The scale consists of 20 items in a five-point Likert format. The questions are answered as true or false and reflect negative expectations. Each answer that matches the given key scores 1 point, while answers that do not match score 0 points. The total score obtained is considered the "hopelessness" score, with higher scores indicating higher levels of hopelessness. The scale's score range is 0-20. The questions on the scale cover emotional, motivational, and cognitive dimensions. The scale consists of three factors: "Feelings about the Future," "Loss of Motivation," and "Future Expectations" (Durak \& Palabıyıkoğlu, 1994). In this study, the Cronbach's Alpha value for hopelessness was calculated as 0.952.
Measured: The research data were collected through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 May 2025
- Study start1 Apr 2023
- Primary completion31 Mar 2025
- Study completion31 Mar 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Oncology PatientsStudies of the same condition, open and under way.
- More trials run by Saglik Bilimleri UniversitesiThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Single group
- Model description
- The research data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes. Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
- Masking
- None (open label)
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- Saglik Bilimleri Universitesi
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gamze TEMİZ, Dr, Study director, Saglik Bilimleri Universitesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06954506
- Sponsor's protocol ID
- Reiki and Oncology Patients
- Other IDs
- Reiki and Oncology Patients
- Status last verified
- Apr 2025
- First submitted
- 7 Apr 2025
- Last updated
- 1 May 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Reiki on Hopelessness Level in Oncology Patients Receiving Chemotherapy Treatment; Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT06954506
- Acronym / sponsor ID
- Reiki and Oncology Patients
- Conditions
- Oncology Patients
- Keywords
- Reiki; oncology; hopelessness
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 32 participants (actual)
- Lead sponsor
- Saglik Bilimleri UniversitesiUniversity, hospital or other
- Study start
- 1 Apr 2023 (actual)
- Primary completion
- 31 Mar 2025 (actual)
- Study completion
- 31 Mar 2025 (actual)
- First posted
- 1 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This quasi-experimental study aims to examine the effect of Reiki on the level of hopelessness in oncology patients.
The study was conducted at İzmir Tepecik Training and Research Hospital with 32 patients in both experimental and control groups. Patients performed Reiki daily for a week following each chemotherapy session for 4 cycles. Data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews. Ethical approval was obtained, and data were analyzed using SPSS.
Detailed description
Reiki is considered a complementary and alternative therapy method that can be effective in coping with such emotional challenges and enhancing psychological well-being. It is thought that Reiki practices, by regulating the flow of energy and providing deep relaxation, can reduce individuals' levels of hopelessness and improve overall quality of life. This study will investigate the effect of Reiki practices on the levels of hopelessness in oncology patients.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The research data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes. Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
| Arm | Type | Receives |
|---|---|---|
| Reiki Group | Experimental | Behavioral: Reiki GroupPatients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week. |
| control group | No intervention | –Only data collection forms were filled in the control group. No intervention was made. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Reiki GroupPatients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week. | Behavioural | Reiki Group |
Primary outcome
The research data will be collected using the "Individual Information Form" and the "Beck Hopelessness Scale" prepared by the researchers in line with the literature.
Time frame: The research data were collected through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes.
Individual Information Form: The form prepared by the researchers consists of 14 questions. Beck Hopelessness Scale: The Beck Hopelessness Scale was developed by Beck and colleagues in 1974 to determine the degree of pessimism an individual has about the future. The scale consists of 20 items in a five-point Likert format. The questions are answered as true or false and reflect negative expectations. Each answer that matches the given key scores 1 point, while answers that do not match score 0 points. The total score obtained is considered the "hopelessness" score, with higher scores indicating higher levels of hopelessness. The scale's score range is 0-20. The questions on the scale cover emotional, motivational, and cognitive dimensions. The scale consists of three factors: "Feelings about the Future," "Loss of Motivation," and "Future Expectations" (Durak \& Palabıyıkoğlu, 1994). In this study, the Cronbach's Alpha value for hopelessness was calculated as 0.952.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2025.
- Individual participant dataSharing planned: No
Related trials for Oncology Patients
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
RecruitingObservational study
Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial
Head & Neck Cancer
RecruitingObservational study
A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC
Non Small Cell Lung Cancer
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Gamze TEMİZ, Dr study director
Saglik Bilimleri Universitesi
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Reiki Group in people with Oncology Patients, run by Saglik Bilimleri Universitesi at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The research data will be collected using the "Individual Information Form" and the "Beck Hopelessness Scale" prepared by the researchers in line with the literature. (time frame: The research data were collected through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025.